Research LetterAtrial function in paroxysmal AF patients with and without heart failure with preserved ejection fraction: Data from the AF-RISK study
Section snippets
Conflict of interest
J.G.L.M.L. has a consultancy agreement with Medtronic. A.A.V reports receiving consulting fees from Amgen, AstraZeneca, Cytokinetics, MyoKardia, Novartis, and Servier, and grant support and consulting fees from Boehringer Ingelheim and Roche Diagnostics.
References (12)
- et al.
Heart failure with preserved ejection fraction and atrial fibrillation: vicious twins
J Am Coll Cardiol
(2016) - et al.
A randomized ablation-based atrial fibrillation rhythm control v rate control trial in patients with heart failure and high burden atrial fibrillation: the RAFT-AF trial rationale and design
Am Heart J
(2021) - et al.
Left atrial structure and function, and left ventricular diastolic dysfunction: JACC state-of-the-art review
J Am Coll Cardiol
(2019) - et al.
Heart failure with preserved ejection fraction or non-cardiac dyspnea in paroxysmal atrial fibrillation: the role of left atrial strain
Int J Cardiol
(2021) - et al.
Molecular mechanism of the association between atrial fibrillation and heart failure includes energy metabolic dysregulation due to mitochondrial dysfunction
J Card Fail
(2019) - et al.
2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the european association for cardio-thoracic surgery (EACTS)
Eur Heart J
(2021)
There are more references available in the full text version of this article.
Cited by (0)
© 2021 Elsevier Inc. All rights reserved.